The Biotech Growth Trust PLC Confirms Compliance with Market Abuse Regulation
The investment trust confirms it has complied with market abuse regulations, providing no material updates on its financial position or outlook.
The investment trust confirms it has complied with market abuse regulations, providing no material updates on its financial position or outlook.
The prominent investment trust has announced a change in its non-executive director's shareholding.
The prominent investment trust is hosting an investor presentation via Investor Meet Company.
The asset management firm has released its monthly fact sheet, providing an update on the performance of its biotechnology-focused investment trust.
The prominent biotech investment trust announces an investor webinar, but the tone of the update suggests the company is facing a challenging operating environment.
The prominent biotech investment trust has appointed a new director with extensive public health leadership experience, as the company navigates the integration of multiple agencies into a unified health security organization.
The prominent investment trust has released its monthly fact sheet, providing an update on its portfolio and activities.
The retailer has announced a capital reduction to provide more flexibility for future share buybacks or returns of capital.
The prominent investment trust is facing challenges, according to its latest update.
The prominent investment trust has released its monthly fact sheet, providing an update on the company's status.